🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

📣 MOOC Viral Hepatitis is open for registration! 🚀Start on 9/04/2024 More info ➡️ fun-mooc.fr/en/courses/vir… #LiverTwitter #ViralHepatitis #LiverDisease Institut Pasteur, since 1887 France Université Numérique boursier jerome Maud Lemoine Karine Lacombe #CitoyensDuWeb Audrey Coilly launay odile @ArnaudFontanet JM Pawlotsky

Génome, IA, traitements du cancer… À Créteil, l’hôpital Henri-Mondor prépare un site de haute expertise ➡️ l.leparisien.fr/kpEF

JM Pawlotsky Assistance Publique – Hôpitaux de Paris (AP-HP) @VilleCreteil Grand Paris Sud Est Avenir - GPSEA Val-de-Marne ARS Île-de-France

Ready for the Olympic Games ?

#easl congress 2024 has started in Milan. Good news: obvious rejuvenation of the audience !

Notice how the ex-SGs are smiling more than the incumbent! Great to meet up again as the EASL family ⁦EASLnews⁩ ⁦Aleksander Krag⁩ ⁦Tom Hemming Karlsen⁩ ⁦⁦JM Pawlotsky⁩

The incredible @dthabut delivering a stellar “State of the Art” lecture on “Hepatic Encephalopathy” #HE at #EASLCongress in Milan! The Future is Manipulation of the Gut Microbiome & the #gutliverbrainaxis 👌International Society for Hepatic Encephalopathy #livertwitter @easlnews Jasmohan Bajaj PROMISE Trial

Our review on «’Unusual’ HCV genotypes subtypes: origin, distribution, sensitivity to direct-acting drugs and behaviour on antiviral treatment and retreatment » is online Gut Journal JM Pawlotsky gut.bmj.com/content/early/…

📢Our new Impact Factor is 26.8🎉 🥇Ranking number 1 in the Hepatology field🥇 👏Thanks to the Editorial Team, untiring peer reviewers & very innovative authors❕ Paolo Angeli EASLnews EASL Education #LiverTwitter

🇫🇷

These are the top 10 moments in #Paris2024 that tough me important LESSONS for career development (and life):

#GUTImage from the #RecentAdvancesInClinicalPractice paper by Erwan Vo quang JM Pawlotsky on "‘Unusual’ HCV genotype subtypes: origin, distribution, sensitivity to direct-acting antiviral drugs and behaviour on antiviral treatment and retreatment" via bit.ly/3yJfIKe

Our review article on « unusual » HCV genotype subtypes, including those that are inherently resistant to DAAs, has now been published by Gut Gut Journal . One of the remaining issues in HCV therapy. Follow the link: bit.ly/3yJfIKe #HCV Erwan Vo quang

#GUTImage from the #RecentAdvancesInClinicalPractice paper by Erwan Vo quang JM Pawlotsky on "‘Unusual’ HCV genotype subtypes: origin, distribution, sensitivity to direct-acting antiviral drugs and behaviour on antiviral treatment and retreatment" via bit.ly/3yJfIKe

EASLnews meeting in the ex-president’s club at #TLM24 AASLD The past, the present and the future of Hepatology !

❕Virological markers for clinical trials in chronic viral hepatitis 🔓#OpenAccess at👉jhep-reports.eu/article/S2589-… #LiverTwitter #hepatitis JM Pawlotsky

📢 Speaker Spotlight at #GHS2025! Dr Jean-Michel Pawlotsky will speak at the 19th Global Hepatitis Summit in LA! Join his session "Optimising strategies to enhance screening and diagnosis for hepatitis B." Don't miss out! #HepatitisResearch #GlobalHealth

Check out our new paper on molecular characterization of RSV infections in elderly patients during the 2023/2024 season in the era of nirsevimab introduction, just published in JID pubmed.ncbi.nlm.nih.gov/39895281/

Are you at #GHS2025? Come find me at my talks! So many great sessions on #HBV & #HCV and amazing people to network with. Great community to work with to achieve #HepatitisElimination by 2030. Join us Thurs 3-3:30 pm for a #StandUpforHepatitis photo at the #NOhep stand!

#davidhockney